cyclosporine has been researched along with Corneal Opacity in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 5 (62.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agla, E; Behar-Cohen, F; BenEzra, D; Besseghir, K; Bourges, JL; Dumont, JM; Gurny, R; Lallemand, F | 1 |
Brown, D; Chang, M; Flynn, KJ; Jester, JV; Nien, CJ | 1 |
Jiang, DY; Qin, B; Xi, XH | 1 |
Birnbaum, F; Böhringer, D; Reinhard, T | 1 |
Reinhard, T; Sundmacher, R | 1 |
Hirano, K; Kachi, S; Miura, M; Takesue, Y | 1 |
Godehardt, E; Pfahl, HG; Reinhard, T; Sundmacher, R | 1 |
Heering, P; Rossa, V; Schmitt-Gräff, A; Sundmacher, R | 1 |
1 trial(s) available for cyclosporine and Corneal Opacity
Article | Year |
---|---|
[Cyclosporin A combined with dexamethasone in preventing and treating immune rejection after penetrating keratoplasty].
Topics: Adult; Corneal Opacity; Cyclosporine; Dexamethasone; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Keratoplasty, Penetrating; Male; Middle Aged | 2003 |
7 other study(ies) available for cyclosporine and Corneal Opacity
Article | Year |
---|---|
Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
Topics: Administration, Topical; Animals; Corneal Edema; Corneal Opacity; Cyclosporine; Cyclosporins; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Graft Rejection; Graft Survival; Immunosuppressive Agents; Incidence; Injections, Intramuscular; Keratoplasty, Penetrating; Prodrugs; Rats; Rats, Inbred BN; Rats, Inbred Lew | 2006 |
Reducing peak corneal haze after photorefractive keratectomy in rabbits: prednisolone acetate 1.00% versus cyclosporine A 0.05%.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Cell Count; Cornea; Corneal Opacity; Corneal Stroma; Cyclosporine; Fibrosis; Immunosuppressive Agents; Lasers, Excimer; Microscopy, Confocal; Photorefractive Keratectomy; Postoperative Complications; Prednisolone; Rabbits; Wound Healing | 2011 |
[Cyclosporin A eyedrops for keratitis nummularis after adenovirus keratoconjunctivitis].
Topics: Adenovirus Infections, Human; Chronic Disease; Corneal Opacity; Cyclosporine; Humans; Immunosuppressive Agents; Keratitis; Keratoconjunctivitis; Ophthalmic Solutions | 2008 |
[Local cyclosporin A therapy in Thygeson superficial punctate keratitis--a pilot study].
Topics: Adolescent; Adult; Child; Cornea; Corneal Opacity; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Keratitis; Keratitis, Herpetic; Male; Middle Aged; Ophthalmic Solutions; Pilot Projects | 1996 |
Unusual corneal deposit after the topical use of cyclosporine as eyedrops.
Topics: Cornea; Corneal Opacity; Cyclosporine; Female; Humans; Immunosuppressive Agents; Middle Aged; Ophthalmic Solutions; Spectrometry, X-Ray Emission; Spectrophotometry, Infrared | 2000 |
[Local cyclosporin A in nummuli after keratoconjunctivitis epidemica. A pilot study].
Topics: Adult; Aged; Aged, 80 and over; Conjunctivitis, Viral; Corneal Opacity; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Treatment Outcome | 2000 |
[Clinical follow-up, histologic findings and therapeutic problems in a patient with bilateral ulcus rodens Mooren].
Topics: Adult; Cataract Extraction; Cornea; Corneal Opacity; Corneal Stroma; Corneal Ulcer; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Humans; Keratoplasty, Penetrating; Male; Ophthalmic Solutions; Postoperative Complications | 1991 |